Label-Free Assessment of the Drug Resistance of Epithelial Ovarian Cancer Cells in a Microfluidic Holographic Flow Cytometer Boosted through Machine Learning-Reference-Cited by-同舟云学术

Label-Free Assessment of the Drug Resistance of Epithelial Ovarian Cancer Cells in a Microfluidic Holographic Flow Cytometer Boosted through Machine Learning

Published:2021-11-12 Issue:46 Volume:6 Page:31046-31057
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Xin Lu¹,Xiao Wen¹,Che Leiping¹,Liu JinJin²,Miccio Lisa³^ORCID,Bianco Vittorio³^ORCID,Memmolo Pasquale³^ORCID,Ferraro Pietro³^ORCID,Li Xiaoping²,Pan Feng¹^ORCID

Affiliation:

1. Key Laboratory of Precision Opto-mechatronics Technology, School of Instrumentation & Optoelectronic Engineering, Beihang University, Beijing 100191, China

2. Department of Obstetrics and Gynecology, Peking University People’s Hospital, Beijing 100044, China

3. CNR, Institute of Applied Sciences & Intelligent Systems (ISASI) “E. Caianiello”, via Campi Flegrei 34, 80078 Pozzuoli, Italy

Funder

Ministry of Science and Technology of the People's Republic of China

Ministero dell???Istruzione, dell???Universit?? e della Ricerca

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

Capital???s Funds for Health improvements and Research

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.1c04204

Reference79 articles.

1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in Oncology: Ovarian Cancer including fallopian tube cancer and primary peritoneal cancer (2019.V1) 2019. 04-30. https://www.nccn.org.

2. A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study

3. Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer

4. Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: Systematic review and meta-analysis of the literature

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classification of paclitaxel-resistant ovarian cancer cells using holographic flow cytometry through interpretable machine learning;Sensors and Actuators B: Chemical;2024-09

2. Automated classification of elliptical cancer cells with stain-free holographic imaging and self-supervised learning;Optics & Laser Technology;2024-07

3. Space Environmental Health: Non-Invasive Holographic Imaging Flow Cytometry for Astronauts Biodosimetry;2024 IEEE International Workshop on Metrology for Living Environment (MetroLivEnv);2024-06-12

4. Particle uptake in cancer cells can predict malignancy and drug resistance using machine learning;Science Advances;2024-05-31

5. Imaging CAR-NK cells targeted to HER2 ovarian cancer with human sodium-iodide symporter-based positron emission tomography;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-09